Search Results
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Junyu Tong in
Google Scholar
PubMed
Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
Search for other papers by Maomei Ruan in
Google Scholar
PubMed
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Hao Fu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Qiong Luo in
Google Scholar
PubMed
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Zhiyan Liu in
Google Scholar
PubMed
Search for other papers by Zhongwei Lv in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
thyroid carcinoma derived from follicular epithelial cells, poorly differentiated thyroid carcinoma (PDTC) ranks between DTC and ATC regarding the degree of differentiation ( 4 ). PDTC was initially proposed as a separate entity by Sakamoto et al. in
Search for other papers by João Roque in
Google Scholar
PubMed
NOVA Medical School | Faculdade de Ciências Médicas of Universidade NOVA de Lisboa, Lisbon, Portugal
Unidade Investigação Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Tiago Nunes Silva in
Google Scholar
PubMed
Search for other papers by Catarina Regala in
Google Scholar
PubMed
Search for other papers by Ricardo Rodrigues in
Google Scholar
PubMed
NOVA Medical School | Faculdade de Ciências Médicas of Universidade NOVA de Lisboa, Lisbon, Portugal
Unidade Investigação Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction The term poorly differentiated thyroid carcinoma (PDTC) was first introduced by Granner and colleagues in 1963, although it was only recognized as a distinct entity by the World Health Organization in 2004 ( 1 , 2 ). In 2006, the
Search for other papers by Tiago Nunes da Silva in
Google Scholar
PubMed
Search for other papers by Edward Limbert in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction Poorly differentiated thyroid carcinoma (PDTC) is a rare type of thyroid cancer accounting for < 6% of all thyroid malignancies [ 1 ]. Nevertheless, it is the second cause of death from follicular cell-derived thyroid cancer after
Search for other papers by Janice Ser Huey Tan in
Google Scholar
PubMed
Search for other papers by Timothy Kwang Yong Tay in
Google Scholar
PubMed
Search for other papers by Enya Hui Wen Ong in
Google Scholar
PubMed
Search for other papers by Michael Fehlings in
Google Scholar
PubMed
Search for other papers by Daniel Shao-Weng Tan in
Google Scholar
PubMed
Search for other papers by Nadiah Binte Sukma in
Google Scholar
PubMed
Search for other papers by Eileen Xueqin Chen in
Google Scholar
PubMed
Search for other papers by Jen-Hwei Sng in
Google Scholar
PubMed
Search for other papers by Connie Siew Poh Yip in
Google Scholar
PubMed
Search for other papers by Kok Hing Lim in
Google Scholar
PubMed
Search for other papers by Darren Wan-Teck Lim in
Google Scholar
PubMed
Search for other papers by Narayanan Gopalakrishna Iyer in
Google Scholar
PubMed
Search for other papers by Jacqueline Siok Gek Hwang in
Google Scholar
PubMed
Search for other papers by Melvin Lee Kiang Chua in
Google Scholar
PubMed
Search for other papers by Mei-Kim Ang in
Google Scholar
PubMed
combination treatment in 8 patients with metastasized anaplastic (ATC) or poorly differentiated thyroid carcinoma (PDTC) . Annals of Oncology 2018 29 viii646 . ( https://doi.org/10.1093/annonc/mdy302.004 ) 17 Dierks C Seufert J Aumann K Ruf J Klein
Center for Health Technology and Services Research (CINTESIS), Porto, Portugal
Search for other papers by Claudia Matta-Coelho in
Google Scholar
PubMed
Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Search for other papers by Helena Vilar in
Google Scholar
PubMed
Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
treatment (surgery plus RAIT), Tg levels under levothyroxine suppression were elevated in 73 of 75 patients, and the remaining 2 patients had a serum Tg < 0.2 ng/mL. One was a patient with a poorly differentiated thyroid carcinoma (PDTC), negative anti
Endocrinology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Search for other papers by Francisco Sousa Santos in
Google Scholar
PubMed
Search for other papers by Rita Joana Santos in
Google Scholar
PubMed
Faculty of Medical Sciences of Lisbon, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
DTC or poorly differentiated thyroid carcinoma (PDTC) (Table 1 ). Of these, a total of 8 patients were excluded from the analysis for the following reasons: 6 because they did not complete more than 2 months of therapy (5 died as a consequence of
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Jan Smit in
Google Scholar
PubMed
tumours are regarded as a separate group. The HC carcinomas are divided into minimally invasive, encapsulated angioinvasive, and widely invasive subtypes, following the same criteria as those applied to FTC. Poorly differentiated thyroid carcinoma (PDTC
Search for other papers by Daniela Dias in
Google Scholar
PubMed
Search for other papers by Inês Damásio in
Google Scholar
PubMed
Search for other papers by Pedro Marques in
Google Scholar
PubMed
Search for other papers by Helder Simões in
Google Scholar
PubMed
Search for other papers by Ricardo Rodrigues in
Google Scholar
PubMed
Search for other papers by Branca Maria Cavaco in
Google Scholar
PubMed
Unidade de Investigação em Patobiologia Molecular (UIPM), Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
Nova Medical School: Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Bardet S & French TUTHYREF N etwork . Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinoma . Journal of Clinical Endocrinology and Metabolism 2012 97 3046 – 3050
UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
CHU Nantes/ICO, Saint-Herblain, France
Search for other papers by Françoise Kraeber-Bodéré in
Google Scholar
PubMed
CHU Nantes/ICO, Saint-Herblain, France
Search for other papers by Caroline Bodet-Milin in
Google Scholar
PubMed
Université de Paris, Paris, France
Search for other papers by Laure Cabanes in
Google Scholar
PubMed
Department of Radiology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Anthony Dohan in
Google Scholar
PubMed
Search for other papers by Pascal Leprince in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, Villejuif, France
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Department of Medical Oncology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Olivier Huillard in
Google Scholar
PubMed
Université de Paris, Paris, France
Department of Endocrinology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
metastases of poorly differentiated thyroid carcinoma diagnosed by echocardiography and magnetic resonance imaging–case report and review of literature . Echocardiography . 2012 ; 29 ( 2 ): E30 – 3 . http://dx.doi.org/10.1111/j.1540-8175.2011.01549.x
Endocrine Tumour Center at West German Cancer Center, Member of ENDO-ERN and EURACAN, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Tim Brandenburg in
Google Scholar
PubMed
Endocrine Tumour Center at West German Cancer Center, Member of ENDO-ERN and EURACAN, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Philipp Muchalla in
Google Scholar
PubMed
University Duisburg-Essen, Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Sarah Theurer in
Google Scholar
PubMed
University Duisburg-Essen, Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Kurt Werner Schmid in
Google Scholar
PubMed
Endocrine Tumour Center at West German Cancer Center, Member of ENDO-ERN and EURACAN, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Dagmar Führer in
Google Scholar
PubMed
pathology revealed a poorly differentiated thyroid carcinoma. Additional workup including esophagogastroduodenoscopy (EGD) showed compression of the oesophagus but no oesophageal infiltration by the tumour. A percutaneous endoscopic gastrostomy tube was